[go: up one dir, main page]

AU6392496A - The combination of topical nasal antihistamines and topical nasal steroids - Google Patents

The combination of topical nasal antihistamines and topical nasal steroids

Info

Publication number
AU6392496A
AU6392496A AU63924/96A AU6392496A AU6392496A AU 6392496 A AU6392496 A AU 6392496A AU 63924/96 A AU63924/96 A AU 63924/96A AU 6392496 A AU6392496 A AU 6392496A AU 6392496 A AU6392496 A AU 6392496A
Authority
AU
Australia
Prior art keywords
topical nasal
combination
antihistamines
steroids
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63924/96A
Inventor
Eileen Helzner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kenvue Brands LLC
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Publication of AU6392496A publication Critical patent/AU6392496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU63924/96A 1995-06-29 1996-06-25 The combination of topical nasal antihistamines and topical nasal steroids Abandoned AU6392496A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US496814 1990-03-20
US49681495A 1995-06-29 1995-06-29
PCT/US1996/010789 WO1997001337A1 (en) 1995-06-29 1996-06-25 The combination of topical nasal antihistamines and topical nasal steroids

Publications (1)

Publication Number Publication Date
AU6392496A true AU6392496A (en) 1997-01-30

Family

ID=23974249

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63924/96A Abandoned AU6392496A (en) 1995-06-29 1996-06-25 The combination of topical nasal antihistamines and topical nasal steroids

Country Status (2)

Country Link
AU (1) AU6392496A (en)
WO (1) WO1997001337A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2256721A1 (en) * 1996-06-04 1997-12-11 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
SE9604486D0 (en) 1996-12-05 1996-12-05 Astra Ab Novel formulation
FR2756739B1 (en) 1996-12-05 2000-04-28 Astra Ab NEW BUDESONIDE FORMULATION
CN1253508A (en) * 1997-04-30 2000-05-17 沃尼尔-朗伯公司 Topical nasal anti-inflammatory composition
EP1788816A3 (en) 1997-11-05 2008-10-15 Sony Corporation Transform domain interpolation for resolution conversion of coded video data
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
US6712803B1 (en) * 1999-08-11 2004-03-30 Howard Paritsky Drug dispensing system
DE19947234A1 (en) * 1999-09-30 2001-04-05 Asta Medica Ag New combination of loteprednol and antihistamines
AR026073A1 (en) 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE
AR026072A1 (en) 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION CONTAINING CICLESONIDE FOR MUCOSA APPLICATION
DK1467762T3 (en) * 2001-12-05 2006-04-10 Alcon Inc Use of an H1 antagonist and rimexolone as a safe steroid for the treatment of rhinitis
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
ATE472329T1 (en) 2002-08-30 2010-07-15 Nycomed Gmbh USE OF THE COMBINATION OF CICLESONIDE AND ANTHISTAMINICS FOR THE TREATMENT OF ALLERGIC RHINITIS
BR0316203A (en) * 2002-11-12 2005-10-04 Alcon Inc Use of an antiallergic agent and a steroid to treat allergic rhinitis
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
WO2005030331A1 (en) * 2003-09-26 2005-04-07 Fairfield Clinical Trials, Llc Combination antihistamine medication
WO2005037245A2 (en) * 2003-10-21 2005-04-28 Direct-Haler A/S A multiple route medication for the treatment of rhinitis and asthma
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
DK2377557T3 (en) 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods for its use
EP1868578A2 (en) 2005-03-23 2007-12-26 Elan Pharma International Limited Nanoparticulate corticosteroid and antihistamine formulations
ATE534390T1 (en) * 2007-11-19 2011-12-15 Bausch & Lomb USE OF LEVOCABASTINE TO MODULATE PROINFLAMMATORY CYTOKINES GENERATION
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
WO2011141929A2 (en) 2010-05-11 2011-11-17 Cadila Healthcare Limited Aqueous pharmaceutical compositions of fluticasone and olopatadine
KR101261230B1 (en) 2010-11-29 2013-05-07 한림제약(주) Pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
CN107737105A (en) * 2017-11-28 2018-02-27 贵州云峰药业有限公司 A kind of nasal cavity agent of azelastine hydrochloride composition spray and production technology

Also Published As

Publication number Publication date
WO1997001337A1 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
AU6392496A (en) The combination of topical nasal antihistamines and topical nasal steroids
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU6046396A (en) Tricot-like pouch for the delivery of topical drugs and cosm etics
AU3003295A (en) Improved inhaler and medicated package
AU1426995A (en) Local delivery and monitoring of drugs
AU7710198A (en) Single pass lead and method of use
AU1021997A (en) Cd100 antigen and uses therefor
AU3280297A (en) Nasal administration of desmopressin
AU4463996A (en) Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
AU6840298A (en) Cosmetic or dermatological use of 7-hydroxylated steroids
AU7143896A (en) Heat-removable bandage and medical tape
AU2438695A (en) Therapeutic phenoxyalkylpyridazines and intermediates therefor
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU6318896A (en) Benzamidoxime derivatives and medicinal use thereof
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AUPN104895A0 (en) Methods of and preparations for the treatment of ailments and disorders
AU6177994A (en) System for the protection of people and/or property
AU6290396A (en) The combination of topical nasal mast cell stabilizers and topical nasal steroids
AU3479495A (en) Alpha-1-antitrypsin and antithrombine-iii variants
AU7638096A (en) An envelope and envelope construction
AU6181196A (en) The combination of topical nasal antihistamines and topical nasal mast cell stabilizers
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU4244593A (en) Pentacyclic antihistamines
AU4552496A (en) Screeding devices and methods of use
AU1921797A (en) Gate for the passage of people